A summary of the numerator and denominators used in the computation of earnings per share follows: | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2024 | | 2023 | | 2024 | | 2023 | | Numerator: | | | | | | | | | Net income | $ | 7,006 | | | $ | 5,490 | | | $ | 2,889 | | | $ | 9,038 | | | Denominators: | | | | | | | | | Number of shares outstanding, end of period: | | | | | | | | | Class A common stock | 57,145 | | | 56,974 | | | 57,145 | | | 56,974 | | | Class B common stock | 988 | | | 988 | | | 988 | | | 988 | | | | | | | | | | | Unvested restricted stock | — | | | (1) | | | — | | | (1) | | Effect of weighted average shares outstanding (1) | (24) | | | (5,076) | | | (63) | | | (5,630) | | | Basic weighted average common shares outstanding | 58,109 | | | 52,885 | | | 58,070 | | | 52,331 | | | Impact of potentially dilutive securities: | | | | | | | | | Dilutive effect of stock options and other stock awards | 90 | | | 95 | | | 91 | | | 96 | | | Diluted weighted average common shares outstanding | 58,199 | | | 52,980 | | | 58,161 | | | 52,427 | | | Anti-dilutive potentially issuable shares | 24 | | | 75 | | | 141 | | | 84 | |
(1)Adjustments in the three and six months ended June 30, 2023 primarily associated with the 6,053 shares of Class A common stock issued as part of the public offering, completed on June 16, 2023, only being outstanding for 14 days in the periods ended June 30, 2023.
|